Single infusion of engineered T-cells achieves lasting asthma remission in mice

Adding regorafenib (Stivarga) to a standard first-line chemoimmunotherapy regimen for HER2-negative metastatic esophagogastric cancer demonstrated “promising” activity in a single-arm phase II study, according to

Cy­to­ki­net­ics’ ex­per­i­men­tal med­i­cine for a ge­net­ic heart con­di­tion known as hy­per­trophic car­diomy­opa­thy helped pa­tients do sig­nif­i­cant­ly bet­ter on an ex­er­cise test that’s used to mea­sure